Drug Profile
Prostate cancer DNA vaccine
Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cancer vaccines; DNA vaccines; Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 14 Jul 1999 New profile
- 14 Jul 1999 Phase-I clinical trials for Prostate cancer in Bulgaria (Unknown route)
- 14 Jul 1999 Preclinical development for Prostate cancer in USA (Unknown route)